Complimentary patient educational materials, disease management tools, slide sets, journal reprints, and more are available for the following products:

• CANCIDAS^® (caspofungin acetate)
• COSOPT^® (dorzolamide hydrochloride-timolol maleate ophthalmic solution)
• COZAAR^® (losartan potassium tablets)
  (See Boxed Warning on use in
  pregnancy in  Prescribing Information)
  (See  Patient Product Information)
• CRIXIVAN^® (indinavir sulfate)
• EMEND^® (aprepitant)
• FOSAMAX^® (alendronate sodium)
  FOSAMAX PLUS D^™ (alendronate sodium/cholecalciferol)
• HYZAAR^® (losartan potassium-hydrochlorothiazide tablets)
  (See Boxed Warning on use in
  pregnancy in  Prescribing Information)
  (See  Patient Product Information)

• INVANZ^® (ertapenem sodium)
• JANUVIA^™ (sitagliptin) tablets
• MAXALT^® (rizatriptan benzoate) Tablets
  MAXALT-MLT^® (rizatriptan benzoate) Orally Disintegrating Tablets
• PROPECIA^® (finasteride)
• SINGULAIR^® (montelukast sodium)
• Merck/Schering-Plough Pharmaceuticals
• ZETIA^® (ezetimibe) Tablets

Viewing files designated with requires a PDF reader